Moreover, exosomal H19 expression levels were related to lymph node metastasis, distant metastasis, and TNM stages, all indicating the H19 potential as a non-invasive biomarker for BC diagnosis (77). The gene discussed is H19; the disease is metastatic malignant neoplasm in the lymph nodes.